Haikou Mingheng Technology
Ordered peptides from Haikou Mingheng Technology? Mail in a sample (US only) and let us test it.
Test my supplyHaikou Mingheng Technology's purity-focus record is strongest in Retatrutide, where close fills and repeated clean results are offset mainly by one recent identity/purity miss. Tirzepatide is more volatile due to large fill overages, while Ipamorelin has an early low-purity/underfill event; absent batch IDs limit traceability despite recent cleaner results.
Chinese registry records, overlapping Mingheng storefronts, sales personas and a non-resolving email domain complicate the marketplace listing. The report also weighs COA-clustering drift and a crypto non-delivery allegation against channel-authenticity evidence.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Haikou Mingheng Technology rows.
Cancel anytime
Ordered peptides from Haikou Mingheng Technology? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
24 Sep 2026 | Pass | Retatrutide Haikou Mingheng Technology | lab name | View COA | |||
24 Sep 2026 | Pass | GHK-Cu Haikou Mingheng Technology | lab name | View COA | |||
5 Sep 2026 | Pass | Retatrutide Haikou Mingheng Technology | lab name | View COA | |||
25 Aug 2026 | Fail | Retatrutide Haikou Mingheng Technology | lab name | View COA | |||
3 Aug 2026 | Pass | Retatrutide Haikou Mingheng Technology | lab name | View COA | |||
10 Jul 2026 | Pass | Tirzepatide Haikou Mingheng Technology | lab name | View COA | |||
16 Jun 2026 | Fail | Retatrutide Haikou Mingheng Technology | lab name | View COA | |||
16 Jun 2026 | Incomplete | Retatrutide Haikou Mingheng Technology | lab name | View COA | |||
30 Apr 2026 | Pass | Tirzepatide Haikou Mingheng Technology | lab name | View COA | |||
27 Apr 2026 | Incomplete | Tirzepatide Haikou Mingheng Technology | lab name | View COA | |||
About Haikou Mingheng Technology test results from Finnrick
Haikou Mingheng Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 34 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Haikou Mingheng Technology peptides in this dataset are GHK-Cu (4 tests), Ipamorelin (5 tests) and Retatrutide (13 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 34 recent tests.
Ordered peptides from Haikou Mingheng Technology? Mail in a sample (US only) and let us test it.
Test my supply